Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates

Key facts

Sponsor

University of Minnesota

Principal Investigator

Kari D Roberts, M.D.

University of Minnesota Masonic Children's Hospital

Intervention

Nasal continuous positive airway pressure (nCPAP)(device)

Enrollment

103 target

Eligibility

All sexes

Timeline

2011 – 2015

Study locations (7)

• Loma Linda University Medical Center, Loma Linda, California, United States
• University of California- San Diego Medical Center, San Diego, California, United States
• Maple Grove Hospital, Maple Grove, Minnesota, United States
• University of Minnesota Children's Hospital, Minneapolis, Minnesota, United States
• North Memorial Hospital, Robbinsdale, Minnesota, United States
• St Paul Children's Hospital, Saint Paul, Minnesota, United States
• University of Wisconsin- Madison, Madison, Wisconsin, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Neonatal acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07437391
  Effect of L-Carnitine Supplementation in Preterm Neonates
  Muhammad Aamir Latif
• RECRUITINGNCT07154134
  Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome
  Tanta University
• RECRUITINGNCT06874478
  Respiratory Distress and Elective Cesarean Section at Term
  Assiut University
• RECRUITINGPHASE4NCT06074380
  Non Inferiority Trial Investigating Surfactants Administered Via MIST
  Endeavor Health
• RECRUITINGNCT06031324
  The Role of Lung Ultrasonography Score in Predicting Prognosis in Term and Late Preterm Newborns With Postnatal Respiratory Distress
  Bursa City Hospital

See all trials for Neonatal acute respiratory distress syndrome →